Ebola Virus
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Ebola Sudan Chimpanzee Adenovirus Vector Vaccine in Healthy Adults (NCT04041570) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-07-02 |
| Investigational Therapeutics for the Treatment of People With Ebola Virus Disease (NCT03719586) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-11-21 |
| Partnership for Research on Ebola Vaccines in Liberia (PREVAIL) (NCT02344407) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-01-20 |
| Placebo Controlled, Dose Response, Safety and Immunogenicity Study of Vesicular Stomatitis Virus (VSV) Ebola Vaccine in Healthy Adults (V920-004) (NCT02314923) | Merck Sharp & Dohme LLC | 2014-12-05 |
| Vaccine Treatment for Ebola Virus in Healthy Adults (V920-001) (NCT02269423) | Merck Sharp & Dohme LLC | 2014-10-13 |
| An Open-Label, Multicenter Study of the Safety and Anti Viral Activity of Brincidofovir (BCV, CMX001) for Ebola Virus Disease (NCT02271347) | Jazz Pharmaceuticals | 2014-10-01 |
Track Ebola Virus automatically
Every clearance here is in the API, with alerts when new ones post.